In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents
Our laboratory has been developing a completely biodegradable coronary stent which is made of bi-Iayers of biodegradable polyesters. This thesis presents the investigations carried out to exploit the drug delivery potential of such a polymeric stent. The main objective of this work was to understand...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2010
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/41732 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-41732 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-417322023-03-04T16:47:49Z In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents Lao, Luciana Lisa Subbu S. Venkatraman School of Materials Science & Engineering DRNTU::Engineering::Materials Our laboratory has been developing a completely biodegradable coronary stent which is made of bi-Iayers of biodegradable polyesters. This thesis presents the investigations carried out to exploit the drug delivery potential of such a polymeric stent. The main objective of this work was to understand and control the release of anti-proliferative drugs from biodegradable polymer films. Such understanding enabled us to explore further the effect of the controlled release of anti-proliferative drug on smooth muscle cell viability. In the bilayer films, an anti-proliferative drug such as paclitaxel is loaded on to the "top" layer that contacts the blood vessel endothelium, while an anti-thrombotic drug such as heparin may be incorporated into the "bottom" of lumen-facing side. Paclitaxel release from P(DL)LGA layer consists of three distinct stages: (i) extremely slow initial release, (ii) accelerated degradative, relaxation-induced release, and (iii) diffusional release. The effect of additives that accelerate release of paclitaxel from P(DL)LGA was studied using in vitro methods. Addition of 10 wt% PEG into P(DL)LGA reduced the induction period by half while replacing P(DL)LGA with PCL resulted in an initial burst followed by a rapid diffusion. DOCTOR OF PHILOSOPHY (MSE) 2010-08-05T08:28:47Z 2010-08-05T08:28:47Z 2008 2008 Thesis Lao, L. L. (2008). In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents. Doctoral thesis, Nanyang Technological University, Singapore. https://hdl.handle.net/10356/41732 10.32657/10356/41732 en 192 p. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
DRNTU::Engineering::Materials |
spellingShingle |
DRNTU::Engineering::Materials Lao, Luciana Lisa In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents |
description |
Our laboratory has been developing a completely biodegradable coronary stent which is made of bi-Iayers of biodegradable polyesters. This thesis presents the investigations carried out to exploit the drug delivery potential of such a polymeric stent. The main objective of this work was to understand and control the release of anti-proliferative drugs from biodegradable polymer films. Such understanding enabled us to explore further the effect of the controlled release of anti-proliferative drug on smooth muscle cell viability. In the bilayer films, an anti-proliferative drug such as paclitaxel is loaded on to the "top" layer that contacts the blood vessel endothelium, while an anti-thrombotic drug such as heparin may be incorporated into the "bottom" of lumen-facing side. Paclitaxel release from P(DL)LGA layer consists of three distinct stages: (i) extremely slow initial release, (ii) accelerated degradative, relaxation-induced release, and (iii) diffusional release. The effect of additives that accelerate release of paclitaxel from P(DL)LGA was studied using in vitro methods. Addition of 10 wt% PEG into P(DL)LGA reduced the induction period by half while replacing P(DL)LGA with PCL resulted in an initial burst followed by a rapid diffusion. |
author2 |
Subbu S. Venkatraman |
author_facet |
Subbu S. Venkatraman Lao, Luciana Lisa |
format |
Theses and Dissertations |
author |
Lao, Luciana Lisa |
author_sort |
Lao, Luciana Lisa |
title |
In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents |
title_short |
In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents |
title_full |
In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents |
title_fullStr |
In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents |
title_full_unstemmed |
In-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents |
title_sort |
in-vitro drug release from biodegradable matrices : analysis, modeling and application in vascular stents |
publishDate |
2010 |
url |
https://hdl.handle.net/10356/41732 |
_version_ |
1759855379934609408 |